News & Analysis as of

Regulatory Requirements Intellectual Property Protection

Paul Hastings LLP

Private Company Report: Q2 2025

Paul Hastings LLP on

This edition of the Private Company Report highlights critical updates and regulatory changes affecting private companies, including the expansion of Qualified Small Business Stock tax benefits under the One Big Beautiful...more

ArentFox Schiff

USPTO Ends Remote PTAB Hearings Effective September 1

ArentFox Schiff on

The US Patent and Trademark Office (USPTO) has announced that, effective September 1, all PTAB hearings will be conducted in person at USPTO offices, marking a departure from the virtual and hybrid formats adopted in recent...more

King & Spalding

EU & UK AI Round-up – July 2025

King & Spalding on

Over the last few months, organisations have accelerated efforts to engage with the requirements of the EU AI Act as we fast approach the date for when rules relating to general purpose AI models (“GPAI models”) come into...more

Rothwell, Figg, Ernst & Manbeck, P.C.

Beyond Guinea Pigs: Patent Risks and Opportunities in AI-Enabled Drug Development

On April 10, 2025, the U.S. Food and Drug Administration (FDA) announced a landmark initiative to phase out animal testing in drug development, signaling a major shift toward human-relevant, science-driven alternatives. This...more

Katten Muchin Rosenman LLP

Get to Know: Anita Hodea - The Katten Kattwalk | Issue 29

Tell me about key moments or mentors that have most influenced your legal career and shaped your current intellectual property (IP) practice?...more

Morrison & Foerster LLP - Government...

What Contractors Need to Know About DoD’s New IP Guidebook

Earlier this year, the Department of Defense (DoD) published an “Intellectual Property Guidebook for DoD Acquisition.” It is the culmination of many years of work and the most insightful data rights guidance out of the...more

Perkins Coie

Delayed EU Code of Practice Provides Compliance Framework for General-Purpose AI Models

Perkins Coie on

Key Takeaways - - The European Commission published its Code of Practice for General-Purpose AI (GPAI) Models on July 10, 2025, following three draft versions and just weeks before the first AI Act obligations take effect....more

Awatif Mohammad Shoqi Advocates & Legal...

Dubai introduces a new law for the protection of the emblems of the Emirate of Dubai and the Government of Dubai.

The New Dubai Emblem Law (Law No. (1) of 2025) was implemented by the government of Dubai to regulate the use of emblems for the Emirate of Dubai and the government of Dubai. The new law repealed the previous law, Law No....more

IR Global

Human in the loop: Making AI work without losing control

IR Global on

How can businesses in your jurisdiction adopt AI and automation responsibly, and what guidance are you offering to ensure regulatory compliance? Implementing AI systems can be a great way to increase productivity in...more

Troutman Pepper Locke

CSC Publishes New Guidance for NIL Deal Review

Troutman Pepper Locke on

On July 10, the College Sports Commission (CSC) published guidance on its website setting out additional information concerning the criteria for evaluating student-athlete NIL deals....more

Skadden, Arps, Slate, Meagher & Flom LLP

SkadBytes Podcast | Tech’s Shifting Landscape: Five Trends Shaping the Conversation

Introducing “SkadBytes,” our newest podcast where Skadden’s IP and Tech team discusses pivotal changes driving tech regulation and innovation. Host Deborah Kirk and colleagues Alistair Ho and Jonathan Stephenson reflect on...more

Offit Kurman

Patents and the FDA: Four Critical Considerations Medical Device Companies Must Know to Successfully Introduce New Products into...

Offit Kurman on

The intersection of patent strategy and FDA regulatory strategy is a critical consideration for medical device companies. A well-integrated approach can create powerful barriers to entry, strengthen intellectual property (IP)...more

Foley & Lardner LLP

Navigating FDA’s Proposed Guidance on AI and Non-Animal Models: Safeguarding Innovation in Drug Development

Foley & Lardner LLP on

In April 2025, the U.S. Food and Drug Administration (FDA) released a landmark guidance titled “Roadmap to Reducing Animal Testing in Preclinical Safety Studies,” outlining its commitment to advancing New Approach...more

ArentFox Schiff

USPTO Raises Annual Cap on Prioritized Patent Examination Requests

ArentFox Schiff on

The US Patent and Trademark Office (USPTO) has finalized a rule increasing the annual limit on accepted requests for prioritized patent examination from 15,000 to 20,000, effective with fiscal year 2025 (FY 2025). This...more

Nelson Mullins Riley & Scarborough LLP

The EU Commission Publishes General-Purpose AI Code of Practice: Compliance Obligations Begin August 2025

On July 10, 2025, after nearly a year of work involving experts and thousands of AI industry participants, the European Commission published its General-Purpose AI Code of Practice, establishing the first detailed compliance...more

Baker Botts L.L.P.

EU Releases General-Purpose AI Code of Practice

Baker Botts L.L.P. on

On July 10, 2025, the EU published its Code of Practice for General-Purpose AI Models, a comprehensive, though not exhaustive, framework designed to guide Artificial Intelligence ("AI") providers in complying with the...more

Smart & Biggar

2025 mid-year highlights in Canadian life sciences IP and regulatory law

Smart & Biggar on

In the first half of 2025, the Rx IP Update team reported on a number of developments in Canadian life sciences IP and regulatory law. Below are our top stories....more

A&O Shearman

Creative deal structures help life sciences innovators ride out the macro storm

A&O Shearman on

Globally, market volatility has eroded confidence and subdued M&A activity. A “wait and see” approach is the prevailing sentiment for many market participants; it is difficult to convince boards to advance deals while...more

MoFo Life Sciences

What Makes a Good Cell and Gene Therapy Application?

MoFo Life Sciences on

Cell and gene therapies represent a transformative frontier in modern medicine, offering potential cures for previously untreatable conditions. However, securing intellectual property (IP) protection for these innovations...more

Skadden, Arps, Slate, Meagher & Flom LLP

The European Health Data Space – What EU Health Care Providers and Data Holders Need To Know

- On 26 March 2025, the European Health Data Space (EHDS) Regulation entered into force. The regulation establishes a comprehensive framework for health-data sharing and access in the EU, with the dual aim of supporting the...more

DLA Piper

Exploring the AI Landscape from Policy to Practice

DLA Piper on

In a recent webinar, Kit Burden, Partner in our Tech and Sourcing team caught up with Gareth Stokes, Global Co-Chair of our Technology Sector and AI Practice, along with Aarushi Jain, Partner in the Technology and Media team...more

American Conference Institute (ACI)

[Virtual Conference] The Legal and Regulatory Think Tank for Working with Influencers - July 16th, 9:00 am - 5:30 pm EST

Influencer marketing isn’t just a trend; it’s the new frontier of digital engagement. But with big opportunities come even bigger responsibilities (and risks). Join us for American Conference Institute and Canadian...more

Paul Hastings LLP

Rising Congressional Warnings to American Universities Signal Greater Scrutiny Over PRC-Linked University Programs

Paul Hastings LLP on

Congress is deepening its scrutiny of U.S. universities that have academic partnerships with Chinese institutions, emphasizing concerns over national security and the use of federal research funding. A series of congressional...more

Fenwick & West LLP

Buy-Side M&A Playbook: Due Diligence in Aerospace & Defense - What Buyers Need to Know

Fenwick & West LLP on

Once a term sheet is in place, buyers must conduct thorough due diligence to uncover potential risks and liabilities. In the aerospace and defense sector, due diligence extends beyond financials to regulatory compliance,...more

Fenwick & West LLP

What We’re Watching Ahead of BIO 2025: Trends Shaping the Future of Biotech

Fenwick & West LLP on

As we head into BIO 2025 in Boston, our teams are closely watching trends in biotech and how those affect financings, business development, IP protection, risk, and litigation strategy. Here are eight key trends we’re...more

289 Results
 / 
View per page
Page: of 12

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide